Federal contract award

75N98018F00007

IFG::OT::IFG: FORUM ON DRUG DISCOVERY, DEVELOPMENT AND TRANSLATION

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Health and Human Services
OfficeNATIONAL INSTITUTES OF HEALTH OLAO
NAICS541690 — Other Scientific and Technical Consulting Services
PSCR799 — Other Management Support Services
Parent award / vehicle75N98018D00029
Set-asideNot reported
Pricing typeCOST NO FEE
Obligations$1.5M
Current contract value$1.5M
Potential contract value / ceiling$1.5M
Start dateSep 6, 2018
Current end dateSep 6, 2023
Potential end dateDec 23, 2024
Latest award activityAug 12, 2026
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 9 of 9 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Aug 12, 2026P00008$-4.5KTO ADMINISTRATIVELY DE-OBLIGATE UNEXPENDED AND EXPIRING FISCAL YEAR 2021 FUNDING IN ACCORDANCE WITH 31 U.S.C. SECTION 1552 (A), IN PREPARATION FOR SEPTEMBER 30, 2026, CLOSING OF THE PERIOD OF AVAILABILITY OF THESE FISCAL YEAR FUNDS.
Dec 30, 2024P00007$-5FORUM ON DRUG DISCOVERY, DEVELOPMENT AND TRANSLATION
Sep 24, 2024P00006$-32.6KFORUM ON DRUG DISCOVERY, DEVELOPMENT AND TRANSLATION
Sep 12, 2022P00005$300.0KFORUM ON DRUG DISCOVERY, DEVELOPMENT AND TRANSLATION
Sep 10, 2021P00004$300.0KFORUM ON DRUG DISCOVERY, DEVELOPMENT AND TRANSLATION
Sep 8, 2020P00003$300.0KFORUM ON DRUG DISCOVERY, DEVELOPMENT AND TRANSLATION
Dec 17, 2019P00002$0IFG::OT::IFG: FORUM ON DRUG DISCOVERY, DEVELOPMENT AND TRANSLATION
Sep 10, 2019P00001$300.0KIFG::OT::IFG: FORUM ON DRUG DISCOVERY, DEVELOPMENT AND TRANSLATION
Sep 6, 20180$300.0KIFG::OT::IFG: FORUM ON DRUG DISCOVERY, DEVELOPMENT AND TRANSLATION

Research next steps

  1. Verify whether remaining options may extend performance beyond the current end date.
  2. Confirm the ordering vehicle and your eligibility or a qualified teaming route.
  3. Review the award scope and buyer evidence before making a bid/no-bid decision.